Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia.

Details

Language :

English

ISSN :

0732183X

Volume :

35

Issue :

2

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

120622525

Full Text :

https://doi.org/10.1200/JCO.2016.67.0893